PeterLabs Holdings Bhd
KLSE:PLABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
PeterLabs Holdings Bhd
Cash from Operating Activities
PeterLabs Holdings Bhd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Cash from Operating Activities
30.9m
|
CAGR 3-Years
69%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Cash from Operating Activities
91.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
12%
|
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Cash from Operating Activities
41.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Cash from Operating Activities
54.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
43%
|
CAGR 10-Years
7%
|
|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Cash from Operating Activities
106.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Cash from Operating Activities
47.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
PeterLabs Holdings Bhd
Glance View
PeterLabs Holdings Bhd.is an investment company, which engages in the manufacture, distribution and trading of animal health and nutrition products. The company is headquartered in Nilai, Negeri Sembilan. The company went IPO on 2011-07-26. The firm is engaged in the manufacturing, distribution and trading of animal health and nutrition products. Its segments include Manufacturing and Trading. The Manufacturing segment is engaged in the manufacturing of animal health and nutrition products. The Trading segment is engaged in the trading and distribution of animal health and nutrition products. Its products include biosecurity and disinfectant, compound feed supplement, feed additives, nutritional premix, pharmaceutical and water-soluble supplement. The firm provides technical information exchange with its customer’s supervisors, technicians and in-house veterinarians, livestock information sharing, post-mortem on diseased animals, blood sampling of diseased animals for testing and individualize latest technologies in the manufacture of feed additives for feed and farming industry.
See Also
What is PeterLabs Holdings Bhd's Cash from Operating Activities?
Cash from Operating Activities
30.9m
MYR
Based on the financial report for Dec 31, 2025, PeterLabs Holdings Bhd's Cash from Operating Activities amounts to 30.9m MYR.
What is PeterLabs Holdings Bhd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
26%
Over the last year, the Cash from Operating Activities growth was 225%. The average annual Cash from Operating Activities growth rates for PeterLabs Holdings Bhd have been 69% over the past three years , 26% over the past five years .
